drugset / Trial / NCT04723303
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
NaSequentialOpen-labelTreatment
Summary
This study will investigate Umbilical Cord Lining Stem Cells (ULSC) as an investigational medicinal product and its use in patients with polymyositis (PM) or dermatomyositis (DM) to see if a single intravenous (IV) infusion of allogeneic umbilical cord lining stem cells (ULSC) safe, tolerable, and feasible to administer.
Timeline
- Start
- 2021-10-06
- Primary completion
- 2023-12-12
- Completion
- 2024-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Umbilical Cord Lining Stem Cells | Cell therapy | 5e+07 cells | Intravenous |
| Subject | Umbilical Cord Lining Stem Cells | Cell therapy | 1e+08 cells | Intravenous |
| Subject | Umbilical Cord Lining Stem Cells | Cell therapy | 2e+08 cells | Intravenous |